RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: This study assessed the axillary lymph node (ALN)-toprimary tumor maximum standard uptake value (SUVmax) ratio (ALN/T SUV ratio) in invasive ductal breast cancer (IDC) on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography (FDG PET/CT) to determine the effectiveness in predicting recurrence-free survival (RFS). Methods: One hundred nineteen IDC patients (mean age, 50.5±10.5 years) with pathologically proven ALN involvement without distant metastasis and preoperative FDG PET/CT were enrolled in the study. SUVmax values of the ALN and primary tumor were obtained on FDG PET/CT, and ALN/T SUV ratio was calculated.
Several factors were evaluated for their effectiveness in predicting RFS. These included several parameters on FDG PET/CT as well as several clinicopathological parameters: pathologic tumor/ node stage; nuclear and histological grade; hormonal state; status with respect to human epidermal growth factor receptor 2, mindbomb E3 ubiquitin protein ligase 1 (MIB-1), and p53; primary tumor size; and ALN size. Results: Among 119 patients with breast cancer, 17 patients (14.3%) experienced relapse during follow-up (mean follow-up, 28.4 months). The ALN/T SUV ratio of the group with disease recurrence was higher than that of the group without recurrence (0.97±1.60 and 0.45±0.40, respectively, p=0.005). Univariate analysis showed that the primary tumor SUVmax, ALN SUVmax, ALN/T SUV ratio, ALN status, nuclear and histological grade, estrogen receptor (ER) status, and MIB-1 status were predictors for RFS. Among these variables, ALN/T SUV ratio with hazard ratio of 4.20 (95% confidence interval [CI], 1.74–10.13) and ER status with hazard ratio of 4.33 (95% CI, 1.06–17.71) were predictors for RFS according to multivariate analysis (p=0.002 and p=0.042, respectively). Conclusion: Our study demonstrated that ALN/T SUV ratio together with ER status was an independent factor for predicting relapse in IDC with metastatic ALN. ALN/T SUV ratio on preoperative FDG PET/CT may be a useful marker for selecting IDC patients that need adjunct treatment to prevent recurrence.

참고문헌 (Reference)

1 Jatoi I, "Why is breast-cancer mortality declining?" 4 : 251-254, 2003

2 Nakajima N, "Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes" 87 : 738-746, 2013

3 Kaida H, "The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancer" 34 : 562-570, 2013

4 Seok JW, "The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes" 27 : 546-553, 2013

5 Ji-Yoon Kim, "The Prognostic Significance of the Lymph Node Ratio in Axillary Lymph Node Positive Breast Cancer" 한국유방암학회 14 (14): 204-212, 2011

6 Okereke IC, "Standard uptake value predicts survival in non-small cell lung cancer" 88 : 911-915, 2009

7 Ohara M, "Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer : usefulness for malignant grade of triple-negative breast cancer" 22 : 958-963, 2013

8 Cerfolio RJ, "Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal(N2)lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer" 83 : 1826-1829, 2007

9 Kaira K, "Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer" 24 : 697-705, 2010

10 Hudis CA, "Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials : the STEEP system" 25 : 2127-2132, 2007